Tag Archives: OCX

Hot Gold Stocks To Invest In 2019

White Gold Corp. (CVE:WGO) Director David D’onofrio purchased 49,000 shares of the business’s stock in a transaction on Friday, April 20th. The shares were acquired at an average price of C$0.80 per share, with a total value of C$39,200.00.

Shares of White Gold stock traded down C$0.06 during trading on Friday, reaching C$0.82. 91,400 shares of the stock were exchanged, compared to its average volume of 51,068. White Gold Corp. has a 1 year low of C$0.65 and a 1 year high of C$2.34.

COPYRIGHT VIOLATION NOTICE: “White Gold Corp. (WGO) Director David D’onofrio Acquires 49,000 Shares” was originally posted by Ticker Report and is the sole property of of Ticker Report. If you are viewing this news story on another website, it was illegally stolen and reposted in violation of US & international trademark & copyright law. The correct version of this news story can be accessed at www.tickerreport.com/banking-finance/3377822/white-gold-corp-wgo-director-david-donofrio-acquires-49000-shares.html.

Hot Gold Stocks To Invest In 2019: OncoCyte Corporation(OCX)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares surged 144.96 percent to close at $265.61 on Thursday in reaction to an encouraging Phase 2 clinical trial update. The clinical-stage biopharmaceutical company said its liver-directed, thyroid hormone receptor called MGL-3196 showed a statistical significance in the primary endpoint of lowering liver fat at 12 weeks and also 36 weeks.
    Viking Therapeutics, Inc. (NASDAQ: VKTX) shares rose 101.01 percent to close at $9.99 on Thursday after falling 4.42 percent on Wednesday.
    Akers Biosciences, Inc. (NASDAQ: AKER) jumped 45.58 percent to close at $0.474. The developer of rapid health information technologies said Wednesday afternoon it was granted a 180-day extension from the Nasdaq Stock Market to meet the requirement of a minimum $1.00 per share closing bid price for 10 straight days.
    Kitov Pharma Ltd (NASDAQ: KTOV) gained 40.93 percent to close at $3.03 after the FDA approved Kitov's Consensi for the treatment of osteoarthritis pain and hypertension.
    China Customer Relations Centers, Inc. (NASDAQ: CCRC) rose 28.21 percent to close at $19.86.
    J.Jill, Inc. (NYSE: JILL) climbed 26.45 percent to close at $7.84 after the company posted upbeat quarterly earnings.
    Curis, Inc. (NASDAQ: CRIS) shares climbed 21.93 percent to close at $2.78 in reaction to an encouraging FDA update. The biotechnology company that focuses on therapies for the treatment of cancer said the FDA granted a Fast Track designation for fimepinostat (CUDC-907) in patients with relapsed or refractory.
    Boxlight Corporation (NASDAQ: BOXL) gained 21.23 percent to close at $7.48.
    Kirkland's, Inc. (NASDAQ: KIRK) rose 16.21 percent to close at $12.83 after reporting upbeat Q1 results.
    The Brink's Company (NYSE: BCO) jumped 16.2 percent to close at $79.25 as the company announced plans to acquire Dunbar Armored for $520 million in cash.
    Applied Optoelectronics, Inc. (NASDAQ: AAOI) rose 15.14 percent to c
  • [By Lisa Levin]

     

    Losers
    Heat Biologics, Inc. (NASDAQ: HTBX) shares tumbled 48.59 percent to close at $1.275 on Thursday after the company priced its $18,000,000 public offering.
    InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) fell 38.77 percent to close at $8.26 on Thursday.
    Check-Cap Ltd. (NASDAQ: CHEK) shares tumbled 27.43 percent to close at $8.81.
    Achaogen, Inc. (NASDAQ: AKAO) dropped 24.76 percent to close at $11.06 in reaction to a disappointing update from an FDA AdCom panel. The FDA panel voted favorably for the company's Plazcomicin for treatment of adults with complicated urinary tract infections, but also voted against the therapy to be used as a treatment for bloodstream infections.
    Anika Therapeutics, Inc. (NASDAQ: ANIK) shares declined 24.68 percent to close at $34.80 after the company posted downbeat quarterly results.
    LSC Communications, Inc. (NASDAQ: LKSD) shares fell 24.22 percent to close at $12.64 following wider-than-expected Q1 loss.
    Cardinal Health, Inc. (NYSE: CAH) fell 21.42 percent to close at $50.80 following downbeat quarterly profit.
    Horizon Global Corporation (NYSE: HZN) dropped 20.42 percent to close at $6.00 following downbeat quarterly earnings.
    Hornbeck Offshore Services, Inc. (NYSE: HOS) slipped 20.11 percent to close at $2.90 following wider-than-expected Q1 loss.
    Esperion Therapeutics, Inc. (NASDAQ: ESPR) fell 19.28 percent to close at $36.93. Esperion Therapeutics stock lost roughly a third of its value Wednesday after the company reported mixed Phase III results for its leading drug candidate, bempedoic acid. JP Morgan downgraded Esperion Therapeutics from Neutral to Underweight.
    Laredo Petroleum, Inc. (NYSE: LPI) declined 17.77 percent to close at $8.98 after the company reported weaker-than-expected Q1 earnings.
    The Habit Restaurants, Inc. (NASDAQ: HABT) dipped 16.1 percent to close at $8.60 after the company reported downbeat quarterly results.
    Arcadia Biosciences, Inc. (N

Hot Gold Stocks To Invest In 2019: CNB Financial Corporation(CCNE)

Advisors’ Opinion:

  • [By Stephan Byrd]

    ILLEGAL ACTIVITY WARNING: “CNB Financial (CCNE) Rating Lowered to Sell at Zacks Investment Research” was posted by Ticker Report and is the sole property of of Ticker Report. If you are accessing this report on another website, it was illegally stolen and reposted in violation of US & international copyright and trademark laws. The legal version of this report can be accessed at www.tickerreport.com/banking-finance/3370450/cnb-financial-ccne-rating-lowered-to-sell-at-zacks-investment-research.html.

  • [By Stephan Byrd]

    BidaskClub upgraded shares of CNB Financial (NASDAQ:CCNE) from a hold rating to a buy rating in a research note released on Thursday morning.

    A number of other research analysts have also recently issued reports on CCNE. ValuEngine cut shares of CNB Financial from a strong-buy rating to a buy rating in a report on Wednesday, May 2nd. Zacks Investment Research raised shares of CNB Financial from a sell rating to a hold rating in a report on Thursday, June 14th. Boenning Scattergood reaffirmed a buy rating on shares of CNB Financial in a report on Tuesday, April 17th. Finally, Keefe, Bruyette & Woods assumed coverage on shares of CNB Financial in a report on Tuesday, April 10th. They issued a market perform rating and a $35.00 price target for the company. Two investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. The stock presently has an average rating of Buy and an average price target of $31.50.

  • [By Max Byerly]

    BidaskClub upgraded shares of CNB Financial (NASDAQ:CCNE) from a hold rating to a buy rating in a research note released on Wednesday morning.

    Several other equities research analysts have also issued reports on CCNE. Boenning Scattergood reissued a buy rating and set a $29.50 price target on shares of CNB Financial in a research report on Monday, February 5th. Zacks Investment Research lowered CNB Financial from a buy rating to a sell rating in a research report on Tuesday, February 20th. ValuEngine raised CNB Financial from a buy rating to a strong-buy rating in a research report on Monday, April 2nd. Finally, Keefe, Bruyette & Woods initiated coverage on CNB Financial in a research report on Tuesday, April 10th. They set a market perform rating and a $35.00 price target on the stock. One research analyst has rated the stock with a sell rating, one has given a hold rating and three have given a buy rating to the company. The stock presently has an average rating of Hold and an average target price of $31.50.

Hot Gold Stocks To Invest In 2019: Siebert Financial Corp.(SIEB)

Advisors’ Opinion:

  • [By Garrett Baldwin]

    William may be right about a sell-off in stocks… in the cryptocurrency space. Over the last week, companies that have billed themselves as blockchain-focused saw their stocks surge. One firm – Long Island Iced Tea changed its name to Long Island Blockchain and watched its stock surge more than triple digits. But today, firms with this exposure are cratering. MGT Capital Investments Inc. (OTCMKTS: MGTI), Long Island Iced Tea Corp. (Nasdaq: LTEA), Riot Blockchain Inc. (Nasdaq: RIOT), and Siebert Financial Corp. (Nasdaq: SIEB) all fell by more than 12% Friday.

  • [By Max Byerly]

    News coverage about Siebert Financial (NASDAQ:SIEB) has been trending somewhat positive this week, according to Accern. Accern rates the sentiment of press coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Siebert Financial earned a media sentiment score of 0.14 on Accern’s scale. Accern also assigned media coverage about the financial services provider an impact score of 45.6527746149751 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

  • [By Shane Hupp]

    Media stories about Siebert Financial (NASDAQ:SIEB) have been trending somewhat positive on Saturday, according to Accern Sentiment Analysis. The research firm identifies positive and negative media coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Siebert Financial earned a coverage optimism score of 0.17 on Accern’s scale. Accern also gave media headlines about the financial services provider an impact score of 45.1943735927385 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

  • [By Shane Hupp]

    News coverage about Siebert Financial (NASDAQ:SIEB) has been trending somewhat positive recently, Accern Sentiment reports. The research firm identifies positive and negative media coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Siebert Financial earned a media sentiment score of 0.12 on Accern’s scale. Accern also assigned news coverage about the financial services provider an impact score of 47.4698738447738 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

Hot Gold Stocks To Invest In 2019: Zosano Pharma Corporation(ZSAN)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Zosano Pharma (NASDAQ:ZSAN) will announce its earnings results after the market closes on Tuesday, May 15th.

    Zosano Pharma (NASDAQ:ZSAN) last issued its quarterly earnings results on Monday, March 12th. The biotechnology company reported ($3.80) EPS for the quarter, topping analysts’ consensus estimates of ($4.80) by $1.00.

  • [By Paul Ausick]

    Zosano Pharma Corp. (NASDAQ: ZSAN) dropped about 17% Tuesday to post a new 52-week low of $0.54 after closing at $0.65 on Friday. Volume was around 720,000, about 10% below the daily average of around 850,000. The company had no specific news.

Hot Performing Stocks To Watch For 2019

Source: ThinkstockJanuary 22, 2018: The S&P 500 closed up 0.8% at 2,832.98. The DJIA closed up 0.55% at 26,214.59. Separately, the Nasdaq was up 1.0% at 7,408.03.

Monday was a positive day for the U.S. markets after they all originally opened flat. All three major averages hit new highs again in this session. Crude oil took started off the week on a positive note. The S&P 500 sectors were mostly positive. The best performing sectors were energy and consumer discretionary up 2.1% and 1.0%, respectively. The worst performing sectors were materials and industrials, down 0.4%, and less than 0.1%, respectively.

Crude oil was up 0.5% at $63.66.

Gold was relatively flat at $1,333.30.

The S&P 500 stock posting the largest daily percentage loss ahead of the close Monday was Chipotle Mexican Grill, Inc. (NYSE: CMG) which traded down roughly 4% at $330.18. The stocks 52-week range is $263.00 to $499.00. Volume was 1.4 million, compared with the daily average of 1.3 million shares.

Hot Performing Stocks To Watch For 2019: Daily Journal Corp. (S.C.)(DJCO)

Advisors’ Opinion:

  • [By Ethan Ryder]

    BidaskClub downgraded shares of Daily Journal (NASDAQ:DJCO) from a buy rating to a hold rating in a research report released on Tuesday.

    Separately, TheStreet raised shares of Daily Journal from a c- rating to a b rating in a report on Monday, February 12th.

Hot Performing Stocks To Watch For 2019: OncoCyte Corporation(OCX)

Advisors’ Opinion:

  • [By Lisa Levin]

     

    Losers
    Heat Biologics, Inc. (NASDAQ: HTBX) shares tumbled 48.59 percent to close at $1.275 on Thursday after the company priced its $18,000,000 public offering.
    InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) fell 38.77 percent to close at $8.26 on Thursday.
    Check-Cap Ltd. (NASDAQ: CHEK) shares tumbled 27.43 percent to close at $8.81.
    Achaogen, Inc. (NASDAQ: AKAO) dropped 24.76 percent to close at $11.06 in reaction to a disappointing update from an FDA AdCom panel. The FDA panel voted favorably for the company's Plazcomicin for treatment of adults with complicated urinary tract infections, but also voted against the therapy to be used as a treatment for bloodstream infections.
    Anika Therapeutics, Inc. (NASDAQ: ANIK) shares declined 24.68 percent to close at $34.80 after the company posted downbeat quarterly results.
    LSC Communications, Inc. (NASDAQ: LKSD) shares fell 24.22 percent to close at $12.64 following wider-than-expected Q1 loss.
    Cardinal Health, Inc. (NYSE: CAH) fell 21.42 percent to close at $50.80 following downbeat quarterly profit.
    Horizon Global Corporation (NYSE: HZN) dropped 20.42 percent to close at $6.00 following downbeat quarterly earnings.
    Hornbeck Offshore Services, Inc. (NYSE: HOS) slipped 20.11 percent to close at $2.90 following wider-than-expected Q1 loss.
    Esperion Therapeutics, Inc. (NASDAQ: ESPR) fell 19.28 percent to close at $36.93. Esperion Therapeutics stock lost roughly a third of its value Wednesday after the company reported mixed Phase III results for its leading drug candidate, bempedoic acid. JP Morgan downgraded Esperion Therapeutics from Neutral to Underweight.
    Laredo Petroleum, Inc. (NYSE: LPI) declined 17.77 percent to close at $8.98 after the company reported weaker-than-expected Q1 earnings.
    The Habit Restaurants, Inc. (NASDAQ: HABT) dipped 16.1 percent to close at $8.60 after the company reported downbeat quarterly results.
    Arcadia Biosciences, Inc. (N

Hot Performing Stocks To Watch For 2019: PennyMac Financial Services, Inc.(PFSI)

Advisors’ Opinion:

  • [By Max Byerly]

    PennyMac Financial Services Inc (NYSE:PFSI) insider David M. Walker sold 10,000 shares of the stock in a transaction on Tuesday, May 15th. The stock was sold at an average price of $20.61, for a total value of $206,100.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Hot Performing Stocks To Watch For 2019: Coca-Cola Bottling Co. Consolidated(COKE)

Advisors’ Opinion:

  • [By Logan Wallace]

    Coca-Cola Bottling Co. Consolidated (NASDAQ: COKE) and Coca Cola Femsa (NYSE:KOF) are both consumer staples companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, dividends, profitability, institutional ownership, analyst recommendations, risk and valuation.

  • [By Ethan Ryder]

    Coca-Cola Bottling Co. Consolidated (NASDAQ:COKE) released its quarterly earnings data on Tuesday. The company reported ($0.85) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.88 by ($1.73), reports. Coca-Cola Bottling Co. Consolidated had a return on equity of 11.63% and a net margin of 2.23%.

Hot Performing Stocks To Watch For 2019: Catabasis Pharmaceuticals, Inc.(CATB)

Advisors’ Opinion:

  • [By Max Byerly]

    These are some of the news articles that may have effected Accern’s analysis:

    Get Catabasis Pharmaceuticals alerts:

    Market Trends Toward New Normal in Church & Dwight Co., Rent-A-Center, Teradata, Catabasis Pharmaceuticals, Tronox, and Callaway Golf Emerging Consolidated Expectations, Analyst Ratings (finance.yahoo.com) Catabasis Pharmaceuticals Inc. – Receive News & Ratings Daily (thecasualsmart.com) Catabasis Pharmaceuticals (CATB) Upgraded by ValuEngine to Sell (americanbankingnews.com) Catabasis Pharmaceuticals to Report First Quarter 2018 Financial Results and Recent Corporate Developments on Thursday, May 10 (finance.yahoo.com) Catabasis Pharmaceuticals Inc (CATB) Given Consensus Rating of “Buy” by Brokerages (americanbankingnews.com)

    A number of analysts recently issued reports on CATB shares. Zacks Investment Research raised Catabasis Pharmaceuticals from a “hold” rating to a “buy” rating and set a $1.75 target price on the stock in a research report on Friday, January 26th. Wedbush reaffirmed an “outperform” rating and issued a $4.00 target price (down previously from $5.00) on shares of Catabasis Pharmaceuticals in a research report on Wednesday, February 14th. Finally, ValuEngine raised Catabasis Pharmaceuticals from a “strong sell” rating to a “sell” rating in a research report on Wednesday, May 2nd. One analyst has rated the stock with a sell rating, one has given a hold rating and six have assigned a buy rating to the stock. Catabasis Pharmaceuticals presently has a consensus rating of “Buy” and a consensus target price of $5.18.